We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
-5.53%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$59.1M
AUM Growth
-$3.34M
Cap. Flow
-$2.46M
Cap. Flow %
-4.15%
Top 10 Hldgs %
91.62%
Holding
24
New
14
Increased
4
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
OIBR.C
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
+$7.72M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.68M
3
BMY icon
Bristol-Myers Squibb
BMY
+$654K
4
INCY icon
Incyte
INCY
+$578K
5
ASMB icon
Assembly Biosciences
ASMB
+$570K

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$41M
2
XPH icon
State Street SPDR S&P Pharmaceuticals ETF
XPH
+$6.45M
3
PBR.A icon
Petrobras Class A
PBR.A
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 14.42%
2 Communication Services 9.5%
3 Consumer Staples 9.08%
4 Financials 4.03%
5 Energy 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KHC icon
1
CALL
Kraft Heinz
KHC
$30.4B
$15.5M 26.29%
+280,000
New +$16.7M
PBR icon
2
CALL
Petrobras
PBR
$121B
$12M 20.28%
+872,100
New +$9.67M
EWZ icon
3
CALL
iShares MSCI Brazil ETF
EWZ
$9.05B
$6.37M 10.77%
+175,000
New +$5.89M
OIBR.C
4
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$5.62M 9.5%
+2,058,301
New +$7.72M
BUD icon
5
AB InBev
BUD
$158B
$5.37M 9.08%
61,313
– –
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.38M 4.03%
11,139
– –
EEM icon
7
iShares MSCI Emerging Markets ETF
EEM
$28B
$2.15M 3.63%
50,000
-950,000
-95% -$41M
SGEN
8
DELISTED
Seagen Inc. Common Stock
SGEN
$1.78M 3%
23,027
+6,503
+39% +$479K
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.63M 2.76%
+16,823
New +$1.68M
INCY icon
10
Incyte
INCY
$23.5B
$1.34M 2.27%
19,450
+8,425
+76% +$578K
FTI icon
11
TechnipFMC
FTI
$30.6B
$923K 1.56%
39,715
– –
BMY icon
12
Bristol-Myers Squibb
BMY
$127B
$684K 1.16%
+11,022
New +$654K
ASMB icon
13
Assembly Biosciences
ASMB
$506M
$542K 0.92%
+1,217
New +$570K
BSX icon
14
Boston Scientific
BSX
$65.8B
$496K 0.84%
+12,886
New +$450K
FOLD
15
DELISTED
Amicus Therapeutics
FOLD
$385K 0.65%
31,810
+13,119
+70% +$183K
EXEL icon
16
Exelixis
EXEL
$13.9B
$323K 0.55%
18,237
+7,921
+77% +$154K
NTRA icon
17
Natera
NTRA
$37.5B
$309K 0.52%
+12,893
New +$312K
PRQR icon
18
ProQR Therapeutics
PRQR
$243M
$302K 0.51%
+15,618
New +$166K
ACAD icon
19
Acadia Pharmaceuticals
ACAD
$4.25B
$266K 0.45%
+12,825
New +$202K
DBVT
20
DBV Technologies
DBVT
$807M
$265K 0.45%
+1,179
New +$240K
IMMU
21
DELISTED
Immunomedics Inc
IMMU
$259K 0.44%
+12,410
New +$294K
BCRX icon
22
BioCryst Pharmaceuticals
BCRX
$2.37B
$202K 0.34%
+26,445
New +$178K
PBR.A icon
23
Petrobras Class A
PBR.A
$107B
– –
-129,578
Closed -$1.15M
XPH icon
24
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
– –
-150,000
Closed -$6.45M

Similar funds

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

JGP Global Gestao de Recursos's Q3 2018 Portfolio in Review

As of Q3 2018, JGP Global Gestao de Recursos held 24 positions worth $59.1M, down 5.3% from $62.5M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $2.46M in Q3 2018, closing 2 positions and reducing 1 holding. Its most notable exit was State Street SPDR S&P Pharmaceuticals ETF, an estimated $6.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 3.8% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, JGP Global Gestao de Recursos opened a new position in OI S.A. American Depositary Shares, each representing five shares of common stock worth $5.62M.

  • JGP Global Gestao de Recursos's largest Q3 2018 buy was OI S.A. American Depositary Shares, each representing five shares of common stock: 2,058,301 shares worth $5.62M.
  • JGP Global Gestao de Recursos added most to Incyte in Q3 2018, an estimated $578K increase.
  • JGP Global Gestao de Recursos's biggest Q3 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $41M.
  • JGP Global Gestao de Recursos fully exited State Street SPDR S&P Pharmaceuticals ETF in Q3 2018, selling an estimated $6.45M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 92% of its $59.1M portfolio in Q3 2018.
  • JGP Global Gestao de Recursos opened 14 new positions and closed 2 in Q3 2018.
  • JGP Global Gestao de Recursos's portfolio value fell 5.3% quarter-over-quarter to $59.1M.

Based on JGP Global Gestao de Recursos's 13F filing for Q3 2018, filed 25 Oct 2018.